Switzerland And Sandpoint

Helsinn Group Makes an Equity Investment for a Minority Interest in Thorne Research, Inc. and Plans to Jointly Commercialize Nutritional Supplement Products With Initial Focus on Meeting the Needs of People Living With Cancer

Older News

LUGANO, Switzerland and SANDPOINT, Idaho, May 11, 2011 - Helsinn Group a rapidly growing pharmaceutical group based in Lugano, Switzerland, announced today the completion of a minority investment in Thorne Research, Inc., a leader in developing and manufacturing pure, high quality nutritional supplements marketed through licensed healthcare practitioners.

MORE..

Corporate
|
Products
|
About Me
|
Contact
|
Privacy Policy